Richard Martin, M.D., M.A. A native of New Jersey, earned his B.S. degree at the University of Michigan, and M.D. at Michigan State College of Human Medicine. He completed an internship at Butterworth Hospital, Grand Rapids, MI, his residency in Primary Care Internal Medicine at the University of Rochester, New York, and a Fellowship in Rheumatology at Mayo Clinic, Rochester, MN. Subsequently at Michigan State University, he earned a M.A. in Educational Psychology & Instructional Design and completed a 3 year Clinical Epidemiology post-doctoral fellowship. He founded the West Michigan Rheumatology in 1991. His research has focused on evaluating emerging therapies for rheumatoid arthritis, raynauds and scleroderma as well as developing decision aids for patients considering biologics.
Andrew Head, M.D. Originally from Cincinnati, OH, earned his B.S. degree at the University of Vermont, and M.D. at the University of Cincinnati. He completed his Internal Medicine residency at The Christ Hospital in Cincinnati, OH. His Rheumatology Fellowship was at the University of Tennessee – Memphis, where he also completed the CHORD fellowship in Health Services Research. He has been with WMR since 2004. He his initial research related to evaluating health disparities of rheumatic disease care. He has extended this to include evaluation of new treatments of rheumatoid, psoriatic arthritis, and gout as well as population studies evaluating determinants of patient choice of biologics.
Aaron Eggebeen, M.D. A native of Grand Rapids and a graduate of Calvin College, MSU College of Human Medicine, and Michigan State University-Spectrum Health IM-Peds residency. He is board certified in pediatrics and internal medicine. He completed his rheumatology fellowship at the University of Pittsburg Medical Center. He has been with the WMR since 2007. While at the University of Pittsburg his research focused on antibody markers of polymyositis and dermatomyositis. He continued thread of research by coordinating with investigators at Pittsburg to lead the NIH funded Rituxan in Myositis Study at WMR. Currently he is the principle investigator at WMR for a first of kind clinical trial evaluating Rituxan to biosimilar molecule for the treatment of rheumatoid arthritis as well as a novel therapy for SLE.
James Birmingham, M.D. A native of Toledo, OH and a graduate of Hillsdale College, Ohio State University School of Medicine, and Michigan State University-Spectrum Health IM-Peds residency. He has completed 4 years of fellowship training in rheumatology at Duke University in Durham, NC. He is has dual certification in both adult and pediatric rheumatology. He has been with the WMR since 2007. Dr. Birmingham is active in national registries of juvenile arthritis as well as clinical trials of emerging therapies for systemic onset juvenile arthritis.
Eric Slavin, M.D. A native of Saginaw, MI, he earned his B.S. degree at the University of Michigan, and M.D. at the Ohio State University College of Medicine. He completed a residency in Internal Medicine at St Vincent Hospital Indianapolis, IN and a Fellowship in Rheumatology at the University of North Carolina, Chapel Hill. He joined WMR in 2015.